Larimar Therapeutics, Inc. Common Stock (LRMR) Stock Price, Quote & AI Analysis

Live LRMR stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Larimar Therapeutics, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Larimar Therapeutics, Inc. Common Stock (LRMR), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

LRMR
Larimar Therapeutics, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
3.060000
High
3.070000
Low
2.900000
Volume
873,455
VWAP
-
Market Cap
$258,411,119.12
52W Range
$1.61 - $5.37
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Mar 23, 2026 Q4
After Hours
EPS Estimate: $-0.5117
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Larimar Therapeutics, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Larimar Therapeutics, Inc. Common Stock Overview

Company information

Company Overview

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Company Details
Market Cap
$254.20M
Shares Outstanding
85,590,400
Weighted Shares Outstanding
83,090,392
CEO
Carole S. Ben-Maimon
Address
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
Employees
65
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Larimar Therapeutics, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...